Volume 14 Supplement 1

Proceedings of the 8th Global Arthritis Research Network (GARN) Meeting and 1st Bio-Rheumatology International Congress (BRIC)

Open Access

Unc93 homolog B1 restricts systemic lethal inflammation by orchestrating TLR7 and TLR9 response

  • Ryutaro Fukui1,
  • Shin-Ichiroh Saitoh1,
  • Atsuo Kanno1,
  • Masahiro Onji1,
  • Takuma Shibata1, 2,
  • Akihiko Ito4,
  • Morikazu Onji5,
  • Mitsuru Matsumoto6,
  • Shizuo Akira7, 8,
  • Nobuaki Yoshida3 and
  • Kensuke Miyake1, 2
Arthritis Research & Therapy201214(Suppl 1):P18

DOI: 10.1186/ar3619

Published: 29 February 2012

Nucleotide sensing-TLRs (Toll-like receptors) recognize pathogen derived-nucleic acids and trigger immune response [1]. Because of the highly conserved structure of nucleic acids, these TLRs have risk to recognize host derived-nucleic acids and induce autoimmune disease, therefore it is important to clarify the mechanisms and control the response.

We found that the responses of TLR7 and TLR9 are balanced reciprocally, and Unc93 homolog B1 (Unc93B1) is a key molecule for this balancing system [2]. Unc93B1 is known as an essential molecule for TLR3, TLR7, and TLR9 responses, and the function depends on its C-terminal region [3]. The balancing function of Unc93B1 is located on 34th aspartic acids from N-terminal, and alanine mutant (D34A) Unc93B1 up-regulates TLR7 response and down-regulates TLR9 response (Figure 1) [2].
Figure 1

The D34A mutation of Unc93B1 up-regulates TLR7 response and down-regulates TLR9 response. (A and B). Empty vector was transfected to bone marrow derived stem cells (BMSCs) from wild tipe mice (gray bars). Empty vector (yellow bars), wild type Unc93B1 expressing vector (blue bars), or D34A Unc93B1 expressing vector (red bars) were transfected to BMSCs from 3d mice. Transfected BMSCs were cultured with puromycin and GM-CSF to differentiate to dendritic cells (DCs). After differentiation, DCs were harvested and stimulated by TLR7 ligands (A, loxoribine, μg/ml) or TLR9 ligands (B, CpG-B, nM). Culture supernatant was corrected and subjected to ELISA for measurement of IL-12p40 (ng/ml).

It is reported that TLR7 or TLR9 response contributes to some kinds of autoimmune disease and TLR7 overexpressed mice develop SLE like autoimmune disease [48]. To investigate the significance of reciprocal TLR7/TLR9 balance in vivo, we generated Unc93b1D34A/D34A mice and observed the phenotypes.

As results, Unc93b1D34A/D34A mice were born according to Mendelian rule but started to die spontaneously at 10 weeks old and over half of Unc93b1D34A/D34A mice died within 1 year (Figure 2A) [9]. Unc93b1D34A/D34A mice developed various phenotypes, for example, splenomegaly, hepatitis, glomerulonephritis, thrombocytopenia, myeloproliferative disorder (Figure 2B-2E). Especially, lethal acute hepatitis was observed in moribund mice and infiltrated myeloid cells in liver were expanded in spleen. These phenotypes are vanished by TLR7 deficient Unc93B1D34A/D34A mice, thus TLR7 hyper-response caused by TLR7/TLR9 balance disruption is factor of phenotypes in Unc93b1D34A/D34A mice (Figure 2).
Figure 2

Unc93b1 D34A/D34A mice develop systemic lethal inflammation spontaneously. (A) Survival curves of Unc93b1WT/WT, Unc93b1D34A/D34A, or Unc93b1D34A/D34ATlr7-/- mice (blue, red, or green line, respectively). (B and C) Macroscopic images of spleen (B) and liver (C). (D) Microscopic analyses of liver. Histological samples were stained by Hematoxyline and Eosine (H&E) or silver impregnation. (E) Platelet counts in peripheral blood from indicated genotypes of mice. Bars in the graph indicate averages.

Not only innate immune system, acquired immune system is also affected by D34A mutation. Expanded memory T cells, up-regulation of ICOS and CD69 on T cells were observed by TLR7 dependent manner and some classes of serum immunoglobulin level is increased in Unc93b1D34A/D34A mice. In addition, Th1 and Th17 cells were expanded and activated in Unc93b1D34A/D34A mice. The activation of T cells were TLR7 dependent, and mature B cell depleted Ighm-/-Unc93b1D34A/D34A mice did not induce T cell activation and moderated phenotypes (Figure 3D and 3E). It suggests that B cells are activated by TLR7 hyper-response, and the B cells activate T cells to generate phenotypes of Unc93b1D34A/D34A mice.However, thrombocytopenia was not completely recovered in Ighm-/-Unc93b1D34A/D34A mice but completely recovered in Rag2-/-Unc93b1D34A/D34A mice. Interaction between cell types and phenotypes should be confirmed as a future plan.
Figure 3

T cells and B cells are activated in Unc93b1 D34A/D34A mice. (A or D) Flow cytometry analysis for memory T cells (A upper, or D) or Th1/Th17 cells (A lower). (B) Expression of ICOS was measured by cell surface staining of CD4+ T cells. Mean fluorescent intensity (MFI) was calculated and indicated by dots. Black bars in the graph indicate average of MFI. (C) Flow cytometry analysis for matrginal zone B cells. (E) Survival curves of Unc93b1D34A/D34A (Red) or Unc93b1D34A/D34AIghm-/- (Green) mice.

Authors’ Affiliations

Division of Infectious Genetics, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo
Laboratory of Innate Immunity, The Institute of Medical Science, The University of Tokyo
Laboratory of Developmental Genetics, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo
Department of Pathology, Faculty of Medicine, Kinki University
Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
Division of Molecular Immunology, Institute for Enzyme Research, University of Tokushima
Laboratory of Host Defense, World Premier International Immunology Frontier Research Center
Department of Host Defense, Research Institute for Microbial Diseases, Osaka University


  1. Blasius AL, Beutler B: Intracellular toll-like receptors. Immunity. 2010, 32: 305-315. 10.1016/j.immuni.2010.03.012.View ArticlePubMedGoogle Scholar
  2. Fukui R, Saitoh S, Matsumoto F, Kozuka-Hata H, Oyama M, Tabeta K, Beutler B, Miyake K: Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J Exp Med. 2009, 206: 1339-1350. 10.1084/jem.20082316.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Tabeta K, Hoebe K, Janssen EM, Du X, Georgel P, Crozat K, Mudd S, Mann N, Sovath S, Goode J, et al: The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol. 2006, 7: 156-164.View ArticlePubMedGoogle Scholar
  4. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S: Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006, 312: 1669-1672. 10.1126/science.1124978.View ArticlePubMedGoogle Scholar
  5. Santiago-Raber ML, Kikuchi S, Borel P, Uematsu S, Akira S, Kotzin BL, Izui S: Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. J Immunol. 2008, 181: 1556-1562.View ArticlePubMedGoogle Scholar
  6. Asagiri M, Hirai T, Kunigami T, Kamano S, Gober HJ, Okamoto K, Nishikawa K, Latz E, Golenbock DT, Aoki K, et al: Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science. 2008, 319: 624-627. 10.1126/science.1150110.View ArticlePubMedGoogle Scholar
  7. Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, Flavell RA, Bolland S: Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity. 2007, 27: 801-810. 10.1016/j.immuni.2007.09.009.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, Cao W, Su B, Nestle FO, Zal T, et al: Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007, 449: 564-569. 10.1038/nature06116.View ArticlePubMedGoogle Scholar
  9. Fukui R, Saitoh SI, Kanno A, Onji M, Shibata T, Ito A, Matsumoto M, Akira S, Yoshida N, Miyake K: Unc93B1 restricts systemic lethal inflammation by orchestrating toll-like receptor 7 and 9 trafficking. Immunity. 2011Google Scholar


© Fukui et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.